[PDF] mdpi.com

Convalescent plasma for hospitalized COVID-19 patients: a single-center experience

M Franchini, C Glingani, GD Donno, G Lucchini… - Life, 2022 - mdpi.com
In Winter 2020, Italy, and in particular the Lombardy region, was the first country in the
Western hemisphere to be hit by the COVID-19 pandemic. Plasma from individuals …
被引用次数：12 相关文章 所有 14 个版本
[HTML] amegroups.org

[HTML][HTML] COVID-19 convalescent plasma: Mechanisms of action and rationale for use: A narrative review

AZ Al-Riyami - Annals of Blood, 2021 - aob.amegroups.org
The use of convalescent plasma (CP) transfusions for patients with coronavirus disease
2019 (COVID-19) has gained great interest during the severe acute respiratory syndrome …
被引用次数：7 相关文章 所有 5 个版本
[PDF] springer.com

Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study

M Rojas, Y Rodríguez, JC Hernández… - BMC Infectious …, 2022 - Springer
Background Convalescent plasma (CP) has been widely used to treat COVID-19 and is
under study. However, the variability in the current clinical trials has averted its wide use in …
被引用次数：11 相关文章 所有 12 个版本
[HTML] nih.gov

Adjunctive treatment with high-titre convalescent plasma in severely and critically ill COVID-19 patients–a safe but futile intervention. A comparative cohort study

WP Hoepler, L Weidner, MT Traugott… - Infectious …, 2021 - Taylor & Francis
Background Convalescent plasma (CP) containing antibodies derived from coronavirus
disease 2019 (COVID-19) survivors has been proposed as a promising therapeutic option …
被引用次数：8 相关文章 所有 9 个版本
[HTML] nih.gov

Early mortality benefit with COVID‐19 convalescent plasma: a matched control study

AG Shenoy, AZ Hettinger, SJ Fernandez… - British journal of …, 2021 - Wiley Online Library
Convalescent plasma can provide passive immunity during viral outbreaks, but the benefit is
uncertain for the treatment of novel coronavirus disease 2019 (COVID‐19). Our goal is to …
被引用次数：50 相关文章 所有 8 个版本
[HTML] sciencedirect.com

[HTML][HTML] Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial

A Gharbharan, C Jordans, L Zwaginga… - Clinical Microbiology …, 2023 - Elsevier
Objectives The potential benefit of convalescent plasma (CP) therapy for coronavirus
disease 2019 (COVID-19) is highest when administered early after symptom onset. Our …
被引用次数：26 相关文章 所有 11 个版本
[HTML] nih.gov

A multicenter, prospective, observational, cohort-controlled study of clinical outcomes following coronavirus disease 2019 (COVID-19) convalescent plasma therapy in …

L Chauhan, J Pattee, J Ford, C Thomas… - Clinical Infectious …, 2022 - academic.oup.com
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
has caused high inpatient mortality and morbidity throughout the world. COVID-19 …
被引用次数：12 相关文章 所有 11 个版本
[PDF] mdpi.com

A Phase II study on the use of convalescent plasma for the treatment of severe COVID-19-a propensity score-matched control analysis

V Pappa, A Bouchla, E Terpos, TP Thomopoulos… - Microorganisms, 2021 - mdpi.com
COVID-19 is a global pandemic associated with increased morbidity and mortality.
Convalescent plasma (CP) infusion is a strategy of potential therapeutic benefit. We …
被引用次数：15 相关文章 所有 14 个版本
[PDF] springer.com

Factors associated with good patient outcomes following convalescent plasma in COVID-19: a prospective phase II clinical trial

D Ibrahim, L Dulipsingh, L Zapatka, R Eadie… - Infectious diseases and …, 2020 - Springer
Abstract Introduction Coronavirus disease 2019 (COVID-19) is a viral respiratory syndrome
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This novel virus …
被引用次数：40 相关文章 所有 13 个版本
[HTML] sciencedirect.com

[HTML][HTML] Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients

M Beraud, EG Meyer, M Lozano, A Bah… - … and Apheresis Science, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) convalescent plasma (CovCP) infusions
have been widely used for the treatment of hospitalized patients with COVID-19. The aims of …
被引用次数：9 相关文章 所有 6 个版本